Matches in SemOpenAlex for { <https://semopenalex.org/work/W4383066823> ?p ?o ?g. }
- W4383066823 abstract "Background: Taxane-induced peripheral neuropathy (TIPN) is an important cause of premature treatment cessation and dose-limitation in cancer therapy. It also reduces quality of life and survivorship in affected patients. Genetic polymorphisms in the CYP3A family have been investigated but the findings have been inconsistent and contradictory. Methods: A systematic review identified 12 pharmacogenetic studies investigating genetic variation in CYP3A4*22 and CYP3A5*3 and TIPN. In our candidate gene study, 288 eligible participants (211 taxane participants receiving docetaxel or paclitaxel, and 77 control participants receiving oxaliplatin) were successfully genotyped for CYP3A4*22 and CYP3A5*3 . Genotyping data was transformed into a combined CYP3A metaboliser phenotype: Poor metabolisers, intermediate metabolisers and extensive metabolisers. Individual genotypes and combined CYP3A metaboliser phenotypes were assessed in relation to neurotoxicity, including by meta-analysis where possible. Results: In the systematic review, no significant association was found between CYP3A5*3 and TIPN in seven studies, with one study reporting a protective association. For CYP3A4*22 , one study has reported an association with TIPN, while four other studies failed to show an association. Evaluation of our patient cohort showed that paclitaxel was found to be more neurotoxic than docetaxel ( p < 0.001). Diabetes was also significantly associated with the development of TIPN. The candidate gene analysis showed no significant association between either SNP ( CYP3A5*3 and CYP3A4*22 ) and the development of TIPN overall, or severe TIPN. Meta-analysis showed no association between these two variants and TIPN. Transformed into combined CYP3A metaboliser phenotypes, 30 taxane recipients were poor metabolisers, 159 were intermediate metabolisers, and 22 were extensive metabolisers. No significant association was observed between metaboliser status and case-control status. Summary: We have shown that the risk of peripheral neuropathy during taxane chemotherapy is greater in patients who have diabetes. CYP3A genotype or phenotype was not identified as a risk factor in either the candidate gene analysis or the systematic review/meta-analysis, although we cannot exclude the possibility of a minor contribution, which would require a larger sample size." @default.
- W4383066823 created "2023-07-05" @default.
- W4383066823 creator A5006847944 @default.
- W4383066823 creator A5012713019 @default.
- W4383066823 creator A5047661674 @default.
- W4383066823 creator A5061670824 @default.
- W4383066823 creator A5088502585 @default.
- W4383066823 date "2023-07-04" @default.
- W4383066823 modified "2023-10-14" @default.
- W4383066823 title "CYP3A genetic variation and taxane-induced peripheral neuropathy: a systematic review, meta-analysis, and candidate gene study" @default.
- W4383066823 cites W1522874901 @default.
- W4383066823 cites W1525132786 @default.
- W4383066823 cites W1541952204 @default.
- W4383066823 cites W1849903145 @default.
- W4383066823 cites W1876387579 @default.
- W4383066823 cites W1946607964 @default.
- W4383066823 cites W1958962196 @default.
- W4383066823 cites W1972199218 @default.
- W4383066823 cites W1973445324 @default.
- W4383066823 cites W1984689348 @default.
- W4383066823 cites W1987093579 @default.
- W4383066823 cites W1988301516 @default.
- W4383066823 cites W1994677523 @default.
- W4383066823 cites W1995962441 @default.
- W4383066823 cites W1997917050 @default.
- W4383066823 cites W1998066146 @default.
- W4383066823 cites W2007302872 @default.
- W4383066823 cites W2009461889 @default.
- W4383066823 cites W2010923269 @default.
- W4383066823 cites W2011914389 @default.
- W4383066823 cites W2014624090 @default.
- W4383066823 cites W2025591905 @default.
- W4383066823 cites W2026496903 @default.
- W4383066823 cites W2029419388 @default.
- W4383066823 cites W2031155689 @default.
- W4383066823 cites W2032355771 @default.
- W4383066823 cites W2032584539 @default.
- W4383066823 cites W2033923474 @default.
- W4383066823 cites W2035681453 @default.
- W4383066823 cites W2035889265 @default.
- W4383066823 cites W2041155215 @default.
- W4383066823 cites W2043133954 @default.
- W4383066823 cites W2044616618 @default.
- W4383066823 cites W2049843692 @default.
- W4383066823 cites W2052389332 @default.
- W4383066823 cites W2059190124 @default.
- W4383066823 cites W2061610829 @default.
- W4383066823 cites W2061871664 @default.
- W4383066823 cites W2073485862 @default.
- W4383066823 cites W2077717033 @default.
- W4383066823 cites W2081545862 @default.
- W4383066823 cites W2082579490 @default.
- W4383066823 cites W2083356003 @default.
- W4383066823 cites W2084092457 @default.
- W4383066823 cites W2107353400 @default.
- W4383066823 cites W2110324196 @default.
- W4383066823 cites W2111819588 @default.
- W4383066823 cites W2114458368 @default.
- W4383066823 cites W2114718178 @default.
- W4383066823 cites W2114826333 @default.
- W4383066823 cites W2122433511 @default.
- W4383066823 cites W2126583835 @default.
- W4383066823 cites W2130666159 @default.
- W4383066823 cites W2137151087 @default.
- W4383066823 cites W2141505882 @default.
- W4383066823 cites W2141570195 @default.
- W4383066823 cites W2147391349 @default.
- W4383066823 cites W2148454282 @default.
- W4383066823 cites W2149687830 @default.
- W4383066823 cites W2151665358 @default.
- W4383066823 cites W2161869158 @default.
- W4383066823 cites W2166615754 @default.
- W4383066823 cites W2170259378 @default.
- W4383066823 cites W2173055827 @default.
- W4383066823 cites W2217472701 @default.
- W4383066823 cites W2227054308 @default.
- W4383066823 cites W2328481386 @default.
- W4383066823 cites W234243781 @default.
- W4383066823 cites W2345610352 @default.
- W4383066823 cites W2471488931 @default.
- W4383066823 cites W2493266198 @default.
- W4383066823 cites W2548195293 @default.
- W4383066823 cites W2582374882 @default.
- W4383066823 cites W2608574443 @default.
- W4383066823 cites W2613929012 @default.
- W4383066823 cites W2620036274 @default.
- W4383066823 cites W2624134239 @default.
- W4383066823 cites W2673256467 @default.
- W4383066823 cites W2746976327 @default.
- W4383066823 cites W2747379890 @default.
- W4383066823 cites W2755218348 @default.
- W4383066823 cites W2758315038 @default.
- W4383066823 cites W2763920048 @default.
- W4383066823 cites W2767315318 @default.
- W4383066823 cites W2774164535 @default.
- W4383066823 cites W2791960492 @default.
- W4383066823 cites W2804010893 @default.
- W4383066823 cites W2807758969 @default.
- W4383066823 cites W2889886478 @default.
- W4383066823 cites W2898174327 @default.